We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Anthony King

Anthony King

Contact Us

Anthony King is a freelance science journalist based in Dublin, Ireland. He reports on a variety of topics in chemical and biological sciences, as well as science policy and health. His articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, EMBO Reports, the Scientist, Chemistry & Industry and more. Anthony has a science degree from Trinity College Dublin and a MSc degree in science communications from Dublin City University. He is vice-president of the Irish Science & Technology Journalists' Association (ISTJA).

Latest Content

How To Accelerate Vaccine Production – And Avoid Speed Bumps

In this article, we discuss key challenges in vaccine development scale up, highlighting various strategies for overcoming them.

Vaccine Needed for a Disfiguring, Deadly Parasitic Disease

Anthony King reviews the urgent need for a vaccine against Leishmaniasis, a parasitic disease that affects one million individuals per year.

Influenza and the Holy Grail Vaccine

A universal flu vaccine to cover all emerging strains is being pursued, but meanwhile the pandemic could result in better, faster seasonal flu shots. Anthony King explores the current research landscape for Technology Networks.

Vaccine Development Lessons From the COVID-19 Pandemic

The COVID-19 pandemic has created a stack of lessons to assist in the development of future vaccines that should help the world develop vaccines for some of the most difficult pathogens to vaccinate against and prepare for future pandemics – if the lessons are remembered.

The Hunt for a Pan-Coronavirus Vaccine

Coronaviruses patently cause destructive pandemics, and it is possible that we will experience another one in our lifetimes. It makes sense to prepare a vaccine for possible future outbreaks, or for new variants of SARS-CoV-2, writes Anthony King.


Troublesome Threesome for Vaccine Development

The need for new vaccines for HIV, Tuberculosis (TB) and malaria are all the greater after the pandemic, but will vaccine advances for SARS-CoV-2 help? Anthony King explores for Technology Networks.

Turning On the Vaccine Tap – The Challenges of Scaling Up Manufacturing

Science writer Anthony King takes a close look at how each of the authorized COVID-19 vaccines are made, and the challenges faced when working to vaccinate the global population.